186 related articles for article (PubMed ID: 24752784)
1. Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts.
Adisetiyo H; Liang M; Liao CP; Jeong JH; Cohen MB; Roy-Burman P; Frenkel B
J Cell Physiol; 2014 Sep; 229(9):1170-6. PubMed ID: 24752784
[TBL] [Abstract][Full Text] [Related]
2. Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.
Chen X; Li Q; Liu X; Liu C; Liu R; Rycaj K; Zhang D; Liu B; Jeter C; Calhoun-Davis T; Lin K; Lu Y; Chao HP; Shen J; Tang DG
Clin Cancer Res; 2016 Sep; 22(17):4505-16. PubMed ID: 27060154
[TBL] [Abstract][Full Text] [Related]
3. CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features.
Geary LA; Nash KA; Adisetiyo H; Liang M; Liao CP; Jeong JH; Zandi E; Roy-Burman P
Mol Cancer Res; 2014 Apr; 12(4):607-21. PubMed ID: 24464914
[TBL] [Abstract][Full Text] [Related]
4. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
[TBL] [Abstract][Full Text] [Related]
5. Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.
Pham LK; Liang M; Adisetiyo HA; Liao CP; Cohen MB; Tahara SM; Frenkel B; Kasahara N; Roy-Burman P
Endocr Relat Cancer; 2013 Dec; 20(6):861-74. PubMed ID: 24042462
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells.
Liao CP; Adisetiyo H; Liang M; Roy-Burman P
Cancer Res; 2010 Sep; 70(18):7294-303. PubMed ID: 20807814
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
[TBL] [Abstract][Full Text] [Related]
8. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.
Wang Z; Wu D; Ng CF; Teoh JY; Yu S; Wang Y; Chan FL
Endocr Relat Cancer; 2018 Jan; 25(1):35-50. PubMed ID: 29042395
[TBL] [Abstract][Full Text] [Related]
9. Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model.
Zhao Y; Peng X; Baldwin H; Zhang C; Liu Z; Lu X
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166151. PubMed ID: 33892077
[TBL] [Abstract][Full Text] [Related]
10. Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1.
Zhang Y; Chen B; Xu N; Xu P; Lin W; Liu C; Huang P
Int J Nanomedicine; 2021; 16():315-327. PubMed ID: 33469288
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells and microenvironment in prostate cancer progression.
Liao CP; Adisetiyo H; Liang M; Roy-Burman P
Horm Cancer; 2010 Dec; 1(6):297-305. PubMed ID: 21761361
[TBL] [Abstract][Full Text] [Related]
12. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.
Jia L; Wu D; Wang Y; You W; Wang Z; Xiao L; Cai G; Xu Z; Zou C; Wang F; Teoh JY; Ng CF; Yu S; Chan FL
Oncogene; 2018 Jun; 37(25):3340-3355. PubMed ID: 29555975
[TBL] [Abstract][Full Text] [Related]
13. PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer.
Yang Y; Bai Y; He Y; Zhao Y; Chen J; Ma L; Pan Y; Hinten M; Zhang J; Karnes RJ; Kohli M; Westendorf JJ; Li B; Zhu R; Huang H; Xu W
Clin Cancer Res; 2018 Feb; 24(4):834-846. PubMed ID: 29167276
[No Abstract] [Full Text] [Related]
14. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells.
Jiao J; Hindoyan A; Wang S; Tran LM; Goldstein AS; Lawson D; Chen D; Li Y; Guo C; Zhang B; Fazli L; Gleave M; Witte ON; Garraway IP; Wu H
PLoS One; 2012; 7(8):e42564. PubMed ID: 22880034
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of FAM84B during prostate cancer progression.
Wong N; Gu Y; Kapoor A; Lin X; Ojo D; Wei F; Yan J; de Melo J; Major P; Wood G; Aziz T; Cutz JC; Bonert M; Patterson AJ; Tang D
Oncotarget; 2017 Mar; 8(12):19218-19235. PubMed ID: 28186973
[TBL] [Abstract][Full Text] [Related]
16. Ratiometric Inclusion of Fibroblasts Promotes Both Castration-Resistant and Androgen-Dependent Tumorigenic Progression in Engineered Prostate Cancer Tissues.
Habbit NL; Anbiah B; Suresh J; Anderson L; Davies ML; Hassani I; Ghosh TM; Greene MW; Prabhakarpandian B; Arnold RD; Lipke EA
Adv Healthc Mater; 2023 Dec; 12(32):e2301139. PubMed ID: 37450342
[TBL] [Abstract][Full Text] [Related]
17. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
Jeong JH; Park SJ; Dickinson SI; Luo JL
Mol Cell; 2017 Jan; 65(1):154-167. PubMed ID: 28041912
[TBL] [Abstract][Full Text] [Related]
18. CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes.
Jung Y; Cackowski FC; Yumoto K; Decker AM; Wang J; Kim JK; Lee E; Wang Y; Chung JS; Gursky AM; Krebsbach PH; Pienta KJ; Morgan TM; Taichman RS
Cancer Res; 2018 Apr; 78(8):2026-2039. PubMed ID: 29431639
[TBL] [Abstract][Full Text] [Related]
19. Skp2 deficiency restricts the progression and stem cell features of castration-resistant prostate cancer by destabilizing Twist.
Ruan D; He J; Li CF; Lee HJ; Liu J; Lin HK; Chan CH
Oncogene; 2017 Jul; 36(30):4299-4310. PubMed ID: 28346424
[TBL] [Abstract][Full Text] [Related]
20. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer.
Dwina Y; Zaid LSM; Saraswati M; Rachmadi L; Kekalih A; Rahadiani N; Louisa M; Agustina H; Mochtar CA; Hamid ARAH
Prostate; 2024 Jun; 84(8):738-746. PubMed ID: 38528654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
